Mutations in Breast Cancer Patients May Explain Resistance to Anti-Estrogen

Mutations In Breast Cancer Patients May Explain Resistance To Anti-Estrogen
The current study, which is published in the journal Nature Genetics, sought to investigate whether genetic mutations are responsible for this drug resistance. According to Dan Robinson, a professor at the University of Michigan Comprehensive Cancer …
Read more on Medical Daily

Health Care Reform Update – Week of November 4, 2013
At odds with this decision are a host of industry stakeholders such as Pharmacy-benefit managers, generic drug manufacturers and commercial health plans because they believe this will result in a rise in spending and shift utilization away from generic …
Read more on The National Law Review